Correction: NLM Does Not Charge for PubMed Data
Oops. Sorry.
The Hitler Meme Hits Peer Review and Having His NIH Grant Application Rejected
Two funny videos of processes in scientific life which many of us can use a good laugh about. Warning — Hitler, unsurprisingly, swears like a sailor when he’s frustrated. The peer review send-up: And, if you want more, there’s the […]
Second Course: Liveblogging the 2012 SSP Closing Session
3:30 p.m.: David C. notes that publishers are in an interesting quandary — they’re castigated for making a profit, yet they’re asked to make huge ongoing investments to make information more findable and usable. Publishers need to bring out the […]
The Big Deal, the Medium Deal, and the Tiny Deal
The Big Deal has emerged because it had to. Where do we go from here? The answer isn’t clear.
The Essence of Science — Feynman Gets It In 63 Seconds
Science begins from a simple premise, then gets really complicated. It’s good to return to the basics, courtesy of this brief primer from the legendary Richard Feynman.
Final Score in the Georgia State Game: Library 94, Publishers 5
The GSU case serves as a strong rebuke for publishers over fair use and copyright claims, while recognizing that some boundaries remain.
The Race to the Bottom — Data, Pertussis, Roads, Fires, and Scholarly Publishing
The culture of cheap has consequences, often expensive ones. Our culture of austerity economics has embraced it, to disastrous effect. Should scholarly publishing be on guard?
ClinicalTrials.gov — Too Many Studies Are Registered Late, Published Late, and Smaller Than Planned
Registering clinical trials after enrollment has commenced may lead to the perception that medical researchers are peeking.
Follow-up on BioMed Central's Sponsored Publication Fees — Granting Funders a View Into Editorial Reports
While BioMed Central’s responses are a mixed bag, a new finding surfaces. And this one might just beat all.
Where There's Smoke — Is Sponsorship of Open Access Author Fees a New Type of Conflict of Interest?
Is there a new form of conflict of interest in the world: BioMed Central’s corporate sponsorship of author fees?
Reproducibility — An Attempt to Test the Psychology Literature Underscores a Growing Fault Line
The growing perception that science is built on sand demands not only some new incentives, but also an understanding that science is not always easy — or possible — to replicate.
An Interview with Cameron Neylon, PLoS' New Director of Advocacy
An interview about open access, funding of science, publishable works, profit motives, and other topics of interest, with one of the more thoughtful advocates of OA publishing, Cameron Neylon.
Making Mistakes in a Good Direction — The God Complex and Experiments
This fascinating TED talk will resonate on many levels with people who read this blog — study design, arrogance, vindication, creativity, inspiration, complexity, evolution, and authority are all dealt with. The topic is “the God complex” — the tendency for […]
Interview with Paula Stephan — Economics, Science, and Doing Better
The author of “How Economics Shapes Science” responds to some questions stimulated by her fine work.
The Emergence of a Citation Cartel
Cheap, effective, and nearly undetectable — editors devise citation cartels to drive up their journal’s impact factor.